The DOI matches its Crossref record; 29 of the 30 references it cites were found in a registry or an index.
Cardiovascular Risk Factors and Common Carotid Artery Caliber and Stiffness in Patients with Cushing’s Disease during Active Disease and 1 Year after Disease Remission
Abstract
Cardiovascular accidents represent the most important cause of death in patients with Cushing's syndrome. This prospective study aims at evaluating carotid arteries by echo-Doppler ultrasonography and clinical and metabolic markers of atherosclerosis in 25 patients with Cushing's disease (CD) before and after 1 yr of remission. Thirty-two sex- and age-matched subjects (control-1) and 32 body mass index-matched subjects (control-2) served as controls. At diagnosis, CD patients had higher body mass index, waist to hip ratio (WHR), total, low-density lipoprotein-cholesterol and total/high-density lipoprotein (HDL) ratio, glucose and insulin, as well as lower HDL-cholesterol than control-1; they had higher WHR and total/HDL ratio and lower HDL-cholesterol than control-2. They also had higher intima-media thickness (IMT), and lower systolic lumen diameter and distensibility coefficient (DC) than either control group. Atherosclerotic plaques were detected in 31.2% of patients, 0 control-1, and 6.2% of control-2 subjects. One year after remission, WHR, LDL-cholesterol, and IMT significantly decreased, whereas systolic lumen diameter and DC significantly increased. However, all of the above parameters were still abnormal compared with control-1, but not control-2. A significant correlation was found between WHR, glucose and insulin levels, and right and left carotid IMT. WHR was the best predictor of left IMT and left DC in active, but not in cured, patients. The duration of hypercortisolism was the best predictor of right DC in active but not in cured patients. In conclusion, patients with CD have severe atherosclerotic damage. The persistence of a metabolic syndrome, vascular damage, and atherosclerotic plaques after cortisol level normalization makes these subjects still at high cardiovascular risk despite disease remission.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“From % to % of patients with endogenous CS have DM, and % to % have defective glucose tolerance, so the overall prevalence of glucose metabolism impairments can come close to %, as shown in Table (, , -).”
From Glucose Metabolism Abnormalities in Cushing Syndrome: From Molecular Basis to Clinical Management (2017) · cites this paper as [183]
In the citing paper
“Controlling hypercortisolism is the first step toward improving glucose metabolism in patients with endogenous CS, but different treatments for hypercortisolism may affect the outcome of diabetes, regardless of how well cortisol excess is corrected (, , , , , , ).”
From Glucose Metabolism Abnormalities in Cushing Syndrome: From Molecular Basis to Clinical Management (2017) · cites this paper as [183]
In the citing paper
“Other prospective studies [Faggiano et al., (); Giordano et al., ()] reported similar findings in patients with CS before and year after remission was achieved thanks to pituitary neurosurgery, pituitary irradiation, or adrenalectomy.”
From Glucose Metabolism Abnormalities in Cushing Syndrome: From Molecular Basis to Clinical Management (2017) · cites this paper as [183]
Citations
Cites
Role of Insulin Resistance in Human Disease
Reaven, G. M. (1988) · Diabetes · doi:10.2337/diab.37.12.1595 · Cited by 12,154
Williams Textbook of Endocrinology
Melmed, S., & Polonsky, K. S. (2016) · Elsevier eBooks · doi:10.1016/c2013-0-15980-6 · Cited by 3,715
Subcutaneous and visceral adipose tissue: their relation to the metabolic syndrome
Wajchenberg, B. L. (2000) · Endocrine Reviews · doi:10.1210/edrv.21.6.0415 · Cited by 2,961
Goodman, D. S. (1988) · Archives of Internal Medicine · doi:10.1001/archinte.1988.00380010040006 · Cited by 2,458
Steinberg, H. O., Chaker, H., Leaming, R., Johnson, A., Brechtel, G., & Baron, A. D. (1996) · Journal of Clinical Investigation · doi:10.1172/jci118709 · Cited by 1,687 · cited 1×
“(28), impairment of glucose tolerance (29), and gestational diabetes (30).”
BackgroundBorch‐Johnsen, K., Neil, A., Balkau, B., Larsen, S. H., Nissinen, A. E. T., Pekkanen, J., Keinanen-Kiukaanniemi, S. M., Hiltunen, L. A., Kivelä, S., Tuomilehto, J. O., et al. (1999) · The Lancet · Cited by 1,272
Diabetes and Endothelial Dysfunction: A Clinical Perspective
Calles-Escandón, J., & Cipolla, M. J. (2001) · Endocrine Reviews · doi:10.1210/edrv.22.1.0417 · Cited by 657
Morbidity and mortality in Cushing's disease: an epidemiological approach.
Etxabe, J., & Vazquez, J. A. (1994) · Clinical Endocrinology · doi:10.1111/j.1365-2265.1994.tb02486.x · Cited by 622
Colao, A., Pivonello, R., Spiezia, S., Faggiano, A., Ferone, D., Filippella, M., Marzullo, P., Cerbone, G., Siciliani, M., & Lombardi, G. (1999) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.84.8.5896 · Cited by 450
Self-citationEndothelial dysfunction in diabetes mellitus.
Cosentino, F., & Lüscher, T. F. (1998) · PubMed · Cited by 259
Flagged first, then by citations
1 of the 30 references couldn’t be matched to a known paper.
Cited by
Sorted by citations
Items 201–300 of 359
Coexistence of bone and vascular disturbances in patients with endogenous glucocorticoid excess
Yano, C., Yokomoto‐Umakoshi, M., Fujita, M., Umakoshi, H., Yano, S., Iwahashi, N., Katsuhara, S., Kaneko, H., Ogata, M., Fukumoto, T., et al. (2022) · Bone Reports · doi:10.1016/j.bonr.2022.101610 · Cited by 11
Moreira, R. P. P., Bachega, T. A. S. S., Machado, M. C., Mendonca, B. B., Bronstein, M. D., & Fragoso, M. C. B. V. (2013) · Clinics · doi:10.6061/clinics/2013(05)01 · Cited by 11
Cardiovascular status in endogenous cortisol excess: the prospective CV-CORT-EX study
Morbach, C., Detomas, M., Sahiti, F., Hoffmann, K., Kroiß, M., Gelbrich, G., Frantz, S., Hahner, S., Heuschmann, P. U., Faßnacht, M., et al. (2024) · European Journal of Endocrinology · doi:10.1093/ejendo/lvae145 · Cited by 10
Prognosis of patients treated for Cushing syndrome
Aulinas, A., Valassi, E., & Webb, S. M. (2014) · Endocrinología y Nutrición (English Edition) · doi:10.1016/j.endoen.2014.01.004 · Cited by 10
Conditioning Factors for High Cardiovascular Risk in Patients with Cushing Syndrome
Boero, L. E., Manavela, M. P., Botta, E., Mallea-Gil, S., Katz, D., Meroño, T., Tetzlaff, W., Martín, M., Rosso, L. A. G., Danilowicz, K., et al. (2015) · Endocrine Practice · doi:10.4158/ep14408.or · Cited by 10
Lamos, E. M., & Munir, K. (2014) · Endocrine Practice · doi:10.4158/ep14068.ra · Cited by 8
Long-term effects of treatment of pituitary adenomas
Pereira, A. M. (2014) · Handbook of clinical neurology · doi:10.1016/b978-0-444-59602-4.00024-1 · Cited by 10
Cushing’s Disease – Quality of Life, Recurrence and Long-term Morbidity
Huguet, I., Ntali, G., Grossman, A. B., & Karavitaki, N. (2015) · touchREVIEWS in Endocrinology · doi:10.17925/ee.2015.11.01.34 · Cited by 10
Kumar, N., Jarial, K., Bhansali, A., Nehra, R., Vyas, S., & Walia, R. (2020) · Indian journal of endocrinology and metabolism · doi:10.4103/ijem.ijem_162_20 · Cited by 4
Su, X., Vicker, N., THOMAS, M. P., Pradaux, F., Halem, H. A., Culler, M. D., & Potter, B. V. L. (2011) · ChemMedChem · doi:10.1002/cmdc.201100144 · Cited by 9
Vertebral Artery Dissecting Aneurysm With Cushing's Syndrome -Case Report-
Kato, M., Tanaka, Y., Kuroda, T., Nakashima, T., & Hattori, T. (2010) · Neurologia medico-chirurgica · doi:10.2176/nmc.50.313 · Cited by 9
How to manage Cushing's disease after failed primary pituitary surgery
Agrawal, N., Urwyler, S. A., Mehta, S., Karavitaki, N., & Feelders, R. A. (2024) · European Journal of Endocrinology · doi:10.1093/ejendo/lvae110 · Cited by 8
Glucocorticoid therapy is a risk factor for cardiovascular diseases
Dzherieva, I. S., Волкова, Н. И., Davidenko, I. Y., Reshetnikov, I., Brovkina, S. S., Avakova, S. M., & Tishchenko, Y. V. (2022) · Medical Herald of the South of Russia · doi:10.21886/2219-8075-2022-13-3-93-106 · Cited by 11
Cushing Syndrome Is Associated With a Higher Risk of Cancer—A Nationwide Cohort Study
Wu, W.-C., Wu, J.-L., Huang, T., Li, C., & Li, H. (2024) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgae405 · Cited by 8
Filippella, M., Davì, M. V., Doveri, G., Lillaz, E., Ciccarelli, A., Massimetti, E., Toaiari, M., Falconi, M., Colao, A., & Faggiano, A. (2010) · Journal of Endocrinological Investigation · doi:10.1007/bf03347062 · Cited by 8
Self-citationBlain, H., Sinaii, N., Zeltser, D., Lyssikatos, C., Belyavskaya, E., Keil, M. F., Bluemke, D. A., Stratakis, C. A., Bandettini, W. P., & Lodish, M. (2019) · Endocrinology Diabetes & Metabolism · doi:10.1002/edm2.54 · Cited by 7
Reimondo, G., Allasino, B., Coletta, M., Pia, A. R., Peraga, G., Zaggia, B., Massaglia, C., Paccotti, P., & Terzolo, M. (2015) · International Journal of Endocrinology · doi:10.1155/2015/674734 · Cited by 8
Walker, M. J. P., Campbell, B. R., Azer, K., Tong, C., Fang, K., Cook, J. J., Forrest, M. J., Kempadoo, K., Wright, S. D., Saltzman, J. S., et al. (2008) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2008.09.013 · Cited by 8
Ayari, H., Legedz, L., Lantelme, P., Feugier, P., Randon, J., Cerutti, C., Lohez, O. D., Scoazec, J., Li, J. Y., GHARBI-CHIHI, J., et al. (2012) · Fundamental and Clinical Pharmacology · doi:10.1111/j.1472-8206.2012.01064.x · Cited by 8
Patients with the metabolic syndrome and a disturbed cortisol balance display more microalbuminuria
Janssen, S. F., Twickler, M., Jublanc, C., Cramer, M. J., & Bruckert, É. (2008) · Diabetes and Vascular Disease Research · doi:10.3132/dvdr.2008.010 · Cited by 8
Çaldır, M. V. (2017) · The Anatolian Journal of Cardiology · doi:10.14744/anatoljcardiol.2016.7425 · Cited by 8
Impact of remission status in endogenous Cushing's syndrome on cancer incidence
Rudman, Y., Fleseriu, M., Masri‐Iraqi, H., Shochat, T., Kushnir, S., Shimon, I., & Akirov, A. (2025) · European Journal of Endocrinology · doi:10.1093/ejendo/lvaf028 · Cited by 7
Koracevic, G. P., Stojkovic, M., Lović, D. B., Pavlović, M., Kostić, T. L., Kutlesic, M. S., Mićić, S., Koraćević, M., & Djordjević, M. (2018) · Current Vascular Pharmacology · doi:10.2174/1570161116666181005122339 · Cited by 7
Szychlińska, M., Rzeczkowska, M., Gontarz-Nowak, K., Matuszewski, W., & Bandurska-Stankiewicz, E. M. (2023) · Journal of Clinical Medicine · doi:10.3390/jcm12144612 · Cited by 7
In what clinical settings should Cushing's syndrome be suspected?
Bruno, O. D., Juárez‐Allen, L., Rossi, M., & Longobardi, V. (2009) · PubMed · Cited by 7
José, P. G. S., Arenas, C., Alonso‐Miguel, D., Moral, I. C., Cuesta-Álvaro, P., & Alenza, M. D. P. (2020) · Journal of Veterinary Internal Medicine · doi:10.1111/jvim.15978 · Cited by 7
Ersöz, F., Erbil, Y., Sarı, S., Salmaslıoğlu, A., İşsever, H., Aral, F., & Özarmağan, S. (2011) · World Journal of Surgery · doi:10.1007/s00268-011-1012-z · Cited by 7
Persistent Comorbidities in Cushing’s Syndrome after Endocrine Cure
Resmini, E. (2014) · Advances in Endocrinology · doi:10.1155/2014/231432 · Cited by 7
Review of resistant hypertension
Ram, C. V. S. (2006) · Current Hypertension Reports · doi:10.1007/s11906-006-0085-9 · Cited by 7
Ehrlich, K., Morbach, C., Reiter, T., Heuschmann, P. U., Hannemann, A., Faßnacht, M., Störk, S., Hahner, S., & Deutschbein, T. (2021) · BMC Endocrine Disorders · doi:10.1186/s12902-020-00665-7 · Cited by 7
Feola, T., Cozzolino, A., Alcubierre, D. D., Pofi, R., Galea, N., Catalano, C., Simeoli, C., Paola, N. D., Campolo, F., Pivonello, R., et al. (2024) · Endocrine · doi:10.1007/s12020-024-03856-7 · Cited by 6
Self-citationDumot, C., Mantziaris, G., Dayawansa, S., Brantley, C., Lee, C., Yang, H., Peker, S., Samancı, Y., Mathieu, D., Tourigny, J.-N., et al. (2024) · Neuro-Oncology · doi:10.1093/neuonc/noae133 · Cited by 6
Jung, S. J., Jeon, Y., Lee, G. B., Shim, J., & Kim, H. C. (2019) · Hypertension Research · doi:10.1038/s41440-019-0331-6 · Cited by 6
Chihaoui, M., Oueslati, I., Khessairi, N., Chaker, F., Cherni, S., Hammami, B., Feki, M., & Yazidi, M. (2023) · Endocrine Regulations · doi:10.2478/enr-2023-0017 · Cited by 6
Stifel, U., Vogel, F., Caratti, G., Reincke, M., & Tuckermann, J. P. (2023) · Hypertension · doi:10.1161/hypertensionaha.123.21185 · Cited by 6
Shivaprasad, K., Kumar, M., Dutta, D., Sinha, B., Mondal, S. A., Maisnam, I., Mukhopadhyay, S., & Chowdhury, S. (2014) · Endocrine Practice · doi:10.4158/ep14399.or · Cited by 6
Dhingra, A., Ganie, M. A., Dharmshaktu, P., Chakraborty, S., Jyotsna, V. P., & Gupta, N. (2019) · Hormone and Metabolic Research · doi:10.1055/a-0879-5122 · Cited by 6
Newell-Price, J. D. C. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-804169-7.00017-9 · Cited by 6
Impairment of Arterial Compliance in Cushing’s Syndrome
Bassareo, P. P., Zedda, A. M., & Mercuro, G. G. (2014) · touchREVIEWS in Endocrinology · doi:10.17925/ee.2014.10.02.161 · Cited by 6
Prise en charge d’un hypercorticisme
Rosales, C., Fierrard, H., BERTAGNA, X. Y., & Raffin‐Sanson, M. (2008) · La Revue de Médecine Interne · doi:10.1016/j.revmed.2007.11.007 · Cited by 6
Zang, Q., Li, F., Ju, Y. H., Wang, J., Luo, J., Liu, W., Ding, T., He, L., & Mo, L. (2025) · Scandinavian Journal of Rheumatology · doi:10.1080/03009742.2025.2488096 · Cited by 5
Therapeutic Repurposing of Antidiabetic Drugs in Diabetes-associated Comorbidities
Pathak, K., Pathak, M. P., Saikia, R., Gogoi, U., Das, R. J., Patowary, P., Kaishap, P. P., Bordoloi, S., Das, J., Sarma, H., et al. (2023) · Current Drug Therapy · doi:10.2174/1574885518666230516150404 · Cited by 6
Hacıoğlu, A., Fırat, S. T., Caglar, A. S., Karaca, Z., Kalay, N., Taheri, S., Tanrıverdi, F., Selcuklu, A., Unluhizarci, K., & Keleştimur, F. (2023) · Journal of Endocrinological Investigation · doi:10.1007/s40618-023-02183-4 · Cited by 5
Syndrome de Cushing : quand y penser ? Comment l’affirmer ?
Guignat, L., & Bertherat, J. Y. (2014) · La Presse Médicale · doi:10.1016/j.lpm.2014.02.005 · Cited by 5
Asymmetric Dimethylarginine Levels and Atherosclerosis Markers in Cushing Syndrome
Özsürekçi, C., Aktürk, M., Özkan, Ç., Gülbahar, Ö., Altınova, A. E., Yalcin, M., Arslan, E., & Törüner, F. B. (2016) · Endocrine Practice · doi:10.4158/ep15990.or · Cited by 5
Witek, P., Zieliński, G., Szamotulska, K., & Zgliczyński, W. (2013) · PubMed · Cited by 5
Glucocorticoid receptors in human epicardial adipose tissue: role of coronary status.
Silaghi, C. A., Silaghi, H., Scridon, T., Pais, R., & Achard, V. (2012) · PubMed · doi:10.3275/7969 · Cited by 5
Bayram, N., Ersoy, R., Sen, D. O., İnançlı, S. S., Durmaz, T., Keleş, T., Bozkurt, E., & Çakır, B. (2010) · Endocrine · doi:10.1007/s12020-009-9295-7 · Cited by 5
Endocrine Disorders that Cause Diabetes
Jennings, R. E., & Hanley, N. A. (2016) · Wiley eBooks · doi:10.1002/9781118924853.ch20 · Cited by 5
Muscogiuri, G., Albertelli, M., Arnaldi, G., Barrea, L., Bellastella, G., Bonomi, M., Caputo, M., Caprio, M., Cignarelli, A., Gioia, L. D., et al. (2026) · Journal of Endocrinological Investigation · doi:10.1007/s40618-026-02862-y · Cited by 4
Self-citationPoredoš, P., Gh, S., Blinc, A., Mikhailidis, D. P., Jensterle, M., Anagnostis, P. G., Pl, A., Studen, K. B., Šabović, M., & Jezovnik, M. K. (2023) · Current Vascular Pharmacology · doi:10.2174/0115701611272145231106053914 · Cited by 4
Barahona, M. J., Resmini, E., Viladés, D., Fernández‐Real, J. M., Ricart, W., Moreno‐Navarrete, J. M., Pons‐Lladó, G., Leta, R., & Webb, S. M. (2014) · Pituitary · doi:10.1007/s11102-014-0566-9 · Cited by 4
Tsurutani, Y., Miyoshi, K., Inoue, K., Takiguchi, T., Saito, J., Omura, M., & Nishikawa, T. (2019) · Endocrine Journal · doi:10.1507/endocrj.ej18-0445 · Cited by 4
Juszczak, A., Morris, D. G., Grossman, A. B., & Nieman, L. K. (2015) · Elsevier eBooks · doi:10.1016/b978-0-323-18907-1.00013-5 · Cited by 4
Septic emboli from aortic valve endocarditis
Skaria, B., Kalra, P. R., & Simpson, I. A. (2004) · Heart · doi:10.1136/hrt.2003.029447 · Cited by 4
Capricchione, A., Winer, N., & Sowers, J. R. (2004) · Current Hypertension Reports · doi:10.1007/s11906-004-0073-x · Cited by 4
Kyle, C. J., Boyle, L. D., Nixon, M., Homer, N. Z. M., Simpson, J., Rutter, A., Ramage, L. E., Kelman, A., Freel, E. M., Andrew, R., et al. (2024) · European Journal of Endocrinology · doi:10.1093/ejendo/lvae144 · Cited by 3
Pituitary Dysfunction as a Cause of Cardiovascular Disease
Gogakos, A. I., Gogakos, T., Kita, M. D., & Efstathiadou, Z. A. (2020) · Current Pharmaceutical Design · doi:10.2174/1381612824999201105165351 · Cited by 3
Wang, B., Yang, Y., Yuan, H., & Li, X. (2021) · International Journal of Endocrinology · doi:10.1155/2021/9536730 · Cited by 3
Obesity-Related Hemodynamic Alterations in Patients with Cushing’s Disease
Jurek, A., Krzesiński, P., Uziębło‐Życzkowska, B., Witek, P., Zieliński, G., Wierzbowski, R., Kazimierczak, A., Banak, M., & Gielerak, G. G. (2024) · Journal of Clinical Medicine · doi:10.3390/jcm13061658 · Cited by 3
Laparoscopic adrenalectomy for co-secreting aldosterone and cortisol adenomas
Lobo, C., Kolinioti, A., Hainsworth, A. J., Bano, G., Mudan, S., & Sharma, A. D. (2012) · International Journal of Surgery · doi:10.1016/j.ijsu.2012.08.017 · Cited by 3
ACTH-Secreting Pituitary Tumors
Pivonello, R., Martino, M. C. D., Iacuaniello, D., Simeoli, C., & Colao, A. (2014) · Elsevier eBooks · doi:10.1016/b978-0-12-801238-3.04102-7 · Cited by 3
Self-citationEuropean survey on metabolic and cardiovascular risk in Cushing syndrome
Mondin, A., Barbot, M., Ceccato, F., Pereira, A. M., Angelousi, A. G., Elenkova, A. P., Žilaitienė, B., Schalin‐Jäntti, C., Herdt, C. D., Kanaka‐Gantenbein, C., et al. (2025) · Journal of Endocrinological Investigation · doi:10.1007/s40618-025-02663-9 · Cited by 2
Iglesias, P., & Iglesias, I. (2025) · Journal of Endocrinological Investigation · doi:10.1007/s40618-025-02767-2 · Cited by 2
Minasyan, M., Gamrat-Żmuda, A., Bryk-Wiązania, A. H., Suchy, W., Bogusławska, A., Rzepka, E., Piwońska‐Solska, B., Majka, K., Hubalewska–Dydejczyk, A., Valassi, E., et al. (2026) · Frontiers in Endocrinology · doi:10.3389/fendo.2026.1785054 · Cited by 2
Schrenk, M., Haenelt, M., Oettle, M., Kroiss, M., Zopp, S., Braun, L., Rubinstein, G., Ritzel, K., Stüfchen, I., Stifel, U., et al. (2026) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgag178 · Cited by 1
Distinct plasma protein profiles after long-term remission of Cushing's disease
Vliet, B. F. V. D., Camilleri, E., Paes, T., Treep, M. M., Dolezal, N., Cordfunke, R. A., Drijfhout, J. W., Biermasz, N. R., Bos, M. H. A., Cannegieter, S. C., et al. (2026) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgag120 · Cited by 3
Lustig, R. H. (2010) · Endocrine updates · doi:10.1007/978-1-4419-7034-3_1 · Cited by 2
Watanabe, D., Morimoto, S., Morishima, N., & Ichihara, A. (2023) · Heart and Vessels · doi:10.1007/s00380-023-02309-x · Cited by 3
Kim, S.-H., Kim, B. H., Han, K., Kong, M., & Song, S. J. (2023) · Ophthalmic Epidemiology · doi:10.1080/09286586.2023.2276193 · Cited by 2
José, P. G. S., Alenza, M. D. P., Alonso‐Miguel, D., Sanz, S., & Arenas, C. (2024) · Animals · doi:10.3390/ani14030511 · Cited by 2
Salvio, G., Ciarloni, A., Aboud, N., Ambo, N., Bordoni, M., Lucchetti, B., Martino, M., Perrone, M., Gasparroni, M., Balercia, G., et al. (2025) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgaf681 · Cited by 2
Cholestasis-associated glucocorticoid overexposure does not increase atherogenesis
van der Geest, R., van der Sluis, R. J., Groen, A. K., Eck, M. V., & Hoekstra, M. (2019) · Journal of Endocrinology · doi:10.1530/joe-19-0079 · Cited by 2
Surgical Treatment of Cushing’s Disease
Tierney, T. S., & Swearingen, B. (2011) · Endocrine updates · doi:10.1007/978-1-4614-0011-0_9 · Cited by 2
Khodakova, I. V., Arapova, S., Sukhanova, G., Chirkova, L., & Rozhinskaia, L. (2010) · Problems of Endocrinology · doi:10.14341/probl201056434-38 · Cited by 1
Glucocorticoid antagonists and 11β-HSD1 inhibitors
Wang, M. (2007) · Drug Discovery Today Therapeutic Strategies · doi:10.1016/j.ddstr.2007.10.001 · Cited by 2
Hipercortisolismo de origen suprarrenal: s?ndrome de Cushing
García, J. M. M. (2008) · Medicine - Programa de Formación Médica Continuada Acreditado · doi:10.1016/s0211-3449(08)73189-8 · Cited by 2
Ferdinand, K. C., Giles, T. D., Falkner, B. E., Toto, R. D., White, A. J., Cushman, W. C., White, W. B., Calhoun, A. W., Jones, D. W., Textor, S. C., et al. (2008) · Cited by 2
Tabarin, A., Collet, D., Galli, F. S., Maire, J., & Loiseau, H. (2006) · EMC - Endocrinologie - Nutrition · doi:10.1016/s1155-1941(06)40170-0 · Cited by 2
Soares, F. A. C., Matheus, J. P., Carvalho, G. L. C., Neuwald, E. B., Pöppl, Á., Valle, S., & Gonzalez, F. (2016) · Korean Journal of Veterinary Research · doi:10.14405/kjvr.2016.56.3.161 · Cited by 3
van Moorsel, D., Henry, R. M. A., Schaper, N. C., van Greevenbroek, M. M. J., van Rossum, E. F. C., Hart, L. M. ‘., Schalkwijk, C. G., Kallen, C., Dekker, J. M., Stehouwer, C. D. A., et al. (2016) · American Journal of Hypertension · doi:10.1093/ajh/hpw196 · Cited by 2
BERTAGNA, X. Y., Guignat, L., Raux-Demay, M. C., Guilhaume, B., & Girard, F. (2010) · Elsevier eBooks · doi:10.1016/b978-0-12-380926-1.10016-1 · Cited by 2
Hormone Excess Syndromes of the Hypothalamic-Pituitary Axis
Agrawal, N., Kim, H. H., Wright, K. E., & Mehta, S. (2020) · Contemporary Endocrinology · doi:10.1007/978-3-030-62187-2_10 · Cited by 2
Capillary microarchitectural changes in Cushing's syndrome
Apaydın, T., Yalçınkaya, Y., Ilgın, C., & Yavuz, D. G. (2022) · Microvascular Research · doi:10.1016/j.mvr.2022.104323 · Cited by 2
Cushing’s Disease – Quality of Life, Recurrence and Long-term Morbidity
Huguet, I., Ntali, G., Grossman, A. B., & Karavitaki, N. (2015) · US Endocrinology · doi:10.17925/use.2015.11.1.55 · Cited by 2
Impairment of Arterial Compliance in Cushing’s Syndrome
Bassareo, P. P., Zedda, A. M., & Mercuro, G. G. (2014) · US Endocrinology · doi:10.17925/use.2014.10.02.143 · Cited by 2
Modern principles of the diagnosis and conservative treatment of Cushing disease
Abdali, A., Astafeva, L., Kalinin, P., Trunin, Y., Chernov, I., Сhmutin, G. E., Badshahzar, A., Sherzad, G., & Keith, S. (2020) · Vestnik nevrologii psihiatrii i nejrohirurgii (Bulletin of Neurology Psychiatry and Neurosurgery) · doi:10.33920/med-01-2010-08 · Cited by 1
Serum Cortisol and Cardiovascular Disease Risk - A Potential Biomarker
Oo, W. J., Lim, C. L., Goh, M. H., & Koh, R. Y. (2025) · Current Cardiology Reviews · doi:10.2174/011573403x328499241106064553 · Cited by 1
Hypertension and kidney dysfunction despite long-term remission of Cushing’s syndrome
Ritzel, K., Fedtke, V., Then, C., Nowak, E., Vogel, F., Braun, L., Zopp, S., Zimmermann, P., Peters, A., Heier, M., et al. (2025) · Journal of Endocrinological Investigation · doi:10.1007/s40618-025-02670-w · Cited by 1
Ekman, B., Quinkler, M. O., Zhang, P., Isidori, A. M., Murray, R. D., Wahlberg, J., & on behalf of the EU-AIR investigators (2025) · Journal of Endocrinological Investigation · doi:10.1007/s40618-025-02657-7 · Cited by 2
Şahin, M. M., Kalçık, M., Yetim, M., Çelik, M. C., Bekar, L., & Karavelioğlu, Y. (2026) · Exploration of Endocrine and Metabolic Diseases · doi:10.37349/eemd.2026.101454 · Cited by 1
Systemic and cardiac pathology induced by a clinically relevant USP8 activating mutation
González, T., Galicia-Martín, A., Calle, D., Cussó, L., Soto‐Navarrete, M. T., Luo, X., Méndez-Peralta, L., Grego‐Bessa, J., & de la Pompa, J. L. (2026) · Disease Models & Mechanisms · doi:10.1242/dmm.052695 · Cited by 1
Stroke patients diagnosed as secondary hypertension: five case reports
Mogi, M., Yamashita, S., Fujisawa, M., Okura, T., Higaki, J., Horiuchi, M., & Katagi, R. (2013) · Nosotchu · doi:10.3995/jstroke.35.350 · Cited by 1
Endocrine System and Cardiovascular Disease
Rotella, C. M., Dicembrini, I., & Pala, L. (2017) · Springer eBooks · doi:10.1007/978-3-319-40010-5_8 · Cited by 1
Di, D. G., Vicennati, V., Rinaldi, E., Morselli‐Labate, A. M., Giampalma, E., Mosconi, C., Pagotto, U., & Pasquali, R. (2012) · 15th International & 14th European Congress of Endocrinology · Cited by 1
Cushing’s disease – cardiovascular and metabolic complications
Mazur, M. I., Zieliński, G., Witek, J., Szamotulska, K., & Witek, P. (2019) · Pediatria i Medycyna Rodzinna · doi:10.15557/pimr.2019.0044 · Cited by 1
Metabolic status in children with Cushing’s disease and its relationship with remission
Moszczyńska, E., Baszyńska–Wilk, M., Bogusz-Wójcik, A., Pasternak-Pietrzak, K., Mazur, M., & Wysocka‐Mincewicz, M. (2023) · Pediatric Endocrinology Diabetes and Metabolism · doi:10.5114/pedm.2023.130026 · Cited by 1
Mikamoto, M., Chang, Y. R., Lee, H., Tritos, N. A., Nachtigall, L. B., Swearingen, B., Miller, K. K., & Jones, P. S. (2025) · Pituitary · doi:10.1007/s11102-025-01536-x · Cited by 1
Acromégalie et maladie de Cushing : séquelles après contrôle et l’hypersécrétion
Rochette, C., Castinetti, F., & Brue, T. C. (2016) · Annales d Endocrinologie · doi:10.1016/s0003-4266(17)30074-4 · Cited by 1
Obesity, Cortisol Excess, and the Hypothalamic–Pituitary–Adrenal Axis
Hunter, L., & Syed, A. A. (2017) · Elsevier eBooks · doi:10.1016/b978-0-323-48559-3.00004-x · Cited by 1
Metadata
- Authors
- Faggiano, A., Pivonello, R., Spiezia, S., De Martino, M. C., Filippella, M., Di Somma, C., Lombardi, G., & Colao, A.
- Affiliations
- Federico II University Hospital (IT)
- Corresponding author
- Colao, Annamaria
- Venue
- The Journal of Clinical Endocrinology & Metabolism
- Publisher
- The Endocrine Society
- Published
- 2003-06
- Volume
- 88
- Issue
- 6
- Pages
- 2527-2533
- ISSN
- 0021-972X (ISSN-L)
- 1945-7197
- OpenAlex
- W2107774273
- Cited by
- 358
- References
- 30
- Citations by year
- 2026: 8 · 2025: 12 · 2024: 17 · 2023: 19 · 2022: 17 · 2021: 13 · 2020: 14 · 2019: 13 · 2018: 7 · 2017: 19 · 2016: 19 · 2015: 18 · 2014: 22 · 2013: 24 · 2012: 20
- FWCI
- 6.81
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- The Journal of Clinical Endocrinology & Metabolism (publishedVersion)
- PubMed (publishedVersion)
- IRIS Research product catalog (Sapienza University of Rome) (submittedVersion)
- Topics
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiovascular Health and Disease Prevention
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pituitary Gland Disorders and Treatments
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Keywords
- Cushing's disease, carotid artery stiffness, carotid intima-media thickness, atherosclerosis, cardiovascular risk factors, remission, waist-to-hip ratio, metabolic syndrome, carotid distensibility, atherosclerotic plaque, HDL cholesterol, insulin resistance
- MeSH terms
- Adult, Arteriosclerosis, Cardiovascular Diseases, Cushing Syndrome, Elasticity, Female, Humans, Longitudinal Studies, Male, Middle Aged, Prospective Studies, Remission Induction, Risk Factors, Time Factors, Ultrasonography, Carotid Artery, Common
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
